viewDirecta Plus PLC

Directa Plus highlights bacteriostatic properties of its graphene

The company's Italian operations remain active and it has highlighted that its graphene could be used in the production of medical devices to ensure better prevention properties for the spread of the virus.

Directa Plus PLC -

Directa Plus PLC (LON:DCTA) has pointed out that its Italian operations are exempt from the restrictions recently imposed by the Italian government.

The producer and supplier of graphene nanoplatelets-based products for use in consumer and industrial markets is classified as a chemical company in Italy and so is in a protected industry deemed to be providing essential goods and services.

The company continues to actively support the Italian authorities, at both local and national level, in their struggle to combat the coronavirus (COCID-19) emergency by making available its technologies.

Directa Plus's graphene is non-toxic and its bacteriostatic properties could be used in the production of medical devices such as masks, gloves and gowns to ensure better prevention properties for the spread of the virus.

"Medical equipment enhanced by graphene could mean a safer working environment for the health workers and all citizens. In the health industry graphene is well known for antibacterial and filtering properties and we will continue to develop protective devices using our non-toxic G+ graphene to benefit our fellow citizens during this emergency,” Directa Plus’s chief executive officer, Giulio Cesareo said in a statement.

Quick facts: Directa Plus PLC

Price: 85.5 GBX

Market: AIM
Market Cap: £52.15 m

Add related topics to MyProactive

Create your account: sign up and get ahead on news and events


The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

In exchange for publishing services rendered by the Company on behalf of Directa Plus PLC named herein, including the promotion by the Company of Directa Plus PLC in any Content on the Site, the Company receives from...



Directa Plus secures EU patent for Grafysorber and advances virus studies on...

Directa Plus PLC's (LON:DCTA) Giulio Cesareo caught up with Proactive London's Andrew Scott after reporting they've secured an EU-wide patent for Grafysorber - its graphene-based technology to treat water and sludge contaminated with hydrocarbons. He also adds some detail around the...

on 27/4/20

2 min read